Transient receptor potential (TRP) channels: a clinical perspective.

Area of Science:

• Molecular biology
• Pharmacology
• Genetics

Background:

• Transient receptor potential (TRP) channels are crucial for sensory signaling and cellular functions.
• Mutations in TRP channel genes cause inherited diseases known as TRP channelopathies, affecting multiple organ systems.
• TRP channels represent significant targets for novel drug development.

Purpose of the Study:

• To review the current state of TRP channel research in drug discovery.
• To highlight the expansion of TRP channel drug discovery into new disease areas.
• To underscore the potential of TRP channels for developing first-in-class therapeutics.

Main Methods:

• Literature review of TRP channel research.
• Analysis of current drug discovery efforts and clinical trials.
• Exploration of TRP channel involvement in various diseases.

Main Results:

• TRP channels are implicated in cardiovascular, renal, skeletal, and nervous system disorders.
• TRP channel antagonists (e.g., TRPV1, TRPV3, TRPA1) are in clinical trials for pain management.
• Drug discovery efforts are expanding to include asthma, cancer, anxiety, cardiac hypertrophy, obesity, and metabolic disorders.

Conclusions:

• TRP channels are versatile targets with potential for treating a wide range of diseases.
• Understanding TRP channel function is key to developing innovative treatments.
• The field of TRP channel drug discovery is rapidly evolving, offering promising therapeutic avenues.